Abstract of this article was viewed 1075 times |
PDF Article downloaded 635 times
How to cite
Sharma, B.; Pilania, P.; Singh, P.
Eur. J. Chem. 2010,
1(4), 325-334.
doi:10.5155/eurjchem.1.4.325-334.195
Sharma, B.; Pilania, P.; Singh, P. QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain.
Eur. J. Chem. 2010,
1(4), 325-334.
doi:10.5155/eurjchem.1.4.325-334.195
Sharma, B., Pilania, P., & Singh, P.
(2010).
QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain.
European Journal of Chemistry, 1(4), 325-334.
doi:10.5155/eurjchem.1.4.325-334.195
Sharma, Brij, Pradeep Pilania, & Prithvi Singh.
"QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain." European Journal of Chemistry [Online], 1.4 (2010): 325-334. Web. 23 Sep. 2023
Sharma, Brij, Pilania, Pradeep, AND Singh, Prithvi.
"QSAR rationales for the 1,2-diarylcyclopentenes as prostaglandin EP1 receptor antagonists: Potentially useful in the treatment of inflammatory pain" European Journal of Chemistry [Online], Volume 1 Number 4 (22 December 2010)
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.